Cargando…
Erratum: Discovery and Preclinical Development of Orally Active Small Molecules That Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103816/ https://www.ncbi.nlm.nih.gov/pubmed/33967815 http://dx.doi.org/10.3389/fphar.2021.672778 |
Ejemplares similares
-
Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism
por: Nataraja, Selva, et al.
Publicado: (2021) -
Erratum: Mechanism Underlying Acupuncture Therapy in Spinal Cord Injury: A Narrative Overview of Preclinical Studies
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: An Integrated Strategy for Rapid Discovery and Identification of Quality Markers in Gardenia Fructus Using an Omics Discrimination-Grey Correlation-Biological Verification Method
por: Frontiers Production Office,
Publicado: (2021) -
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: Frontiers Production Office,
Publicado: (2022)